The E-Fund (VANTEC Entrepreneurs Fund VCC Inc.) was established in 2011 to invest in promising new ventures in British Columbia in a wide range of industry sectors. They are focused on co-investing with other angel investors and early-stage venture capital firms in seed-stage companies with high growth opportunities. The E-Fund involves specific investors in the investment due diligence process depending on their industry experience and knowledge and their particular technical expertise. It is their goal to become the ‘Go-to Braintrust’ for active and in-depth angel investing.
Lucent BioSciences is a Vancouver-based AgTech start-up driven by accelerating the transition of agriculture to sustainability. Lucent Bio has developed a novel patent-pending fertilizer for agriculture called "Soileos'' using cellulose fibre as a delivery agent. The product improves yield and soil health, and is climate positive, non-polluting, and sustainable.
BarrelWise
Seed Round in 2020
BarrelWise Technologies specializes in innovative solutions for the wine industry, focusing on improving production and analysis processes. Their flagship product, the FS1 System, revolutionizes routine free SO2 checks by allowing wineries to conduct these tests directly in the cellar, significantly reducing the time required from days to mere minutes while ensuring lab-level accuracy. Additionally, the technology facilitates various barrel management tasks, such as topping, sampling, sulfating, and chemical analysis, all without the need to open the barrel. This integrated approach enhances operational efficiency for wineries in regions like British Columbia, California, and Washington.
Arbutus Medical
Seed Round in 2020
Arbutus Medical Inc., founded in 2014 and headquartered in Vancouver, Canada, specializes in the development and manufacturing of surgical power tools aimed at enhancing surgical efficiency and accessibility. The company offers a range of products, including its flagship orthopedic power tool system, which features innovative solutions such as the HEX and PRO drill kits, as well as sterile-packed orthopedic procedure kits. These tools are designed to meet the needs of various healthcare settings, including trauma centers, veterinary hospitals, military deployments, and hospitals in over 30 low- and middle-income countries. Arbutus Medical focuses on "frugal innovation," aiming to reduce healthcare costs and improve access to orthopedic surgery for millions of patients by 2030.
CuePath Innovation
Angel Round in 2020
CuePath Innovation Inc. is a health technology company based in Vancouver, Canada, founded in 2015. The company specializes in developing a mobile application and smart disposable medication packaging aimed at helping caregivers monitor the medication intake of elderly patients and other vulnerable individuals. By facilitating remote tracking, CuePath's platform connects seniors with their caregivers and healthcare professionals, allowing families to ensure that their loved ones adhere to their medication regimens. This innovative approach not only promotes medication compliance but also supports the independence and health of seniors, thereby alleviating the stress associated with caregiving.
Starling Minds
Seed Round in 2019
Starling Minds Inc. is a Vancouver-based company founded in 2013 that specializes in digital mental health therapy. It offers an online Cognitive Behavioral Therapy program designed to address stress, burnout, anxiety, and depression in workplace settings. The company provides comprehensive solutions for various sectors, including business, disability management, education, healthcare, insurance, and workers' compensation. By utilizing an artificial intelligence-powered platform, Starling Minds licenses its technology to insurance payers, healthcare providers, and employers in a business-to-business model. This approach aims to alleviate the chronic shortage of affordable mental health professionals by offering effective support for employees, facilitating their return to work, and promoting overall workplace productivity and mental well-being.
Mesentech
Seed Round in 2019
Mesentech Inc. is a regenerative medicine company based in Vancouver, Canada, specializing in the development of therapeutics that target bone-related diseases. The company utilizes a unique prodrug platform that delivers bi-specific small-molecule therapeutics selectively to bone tissue, minimizing side effects associated with systemic exposure. Its lead product, MES1007, is a bone-targeted prodrug of a prostaglandin mimetic, designed to potentially reverse bone loss linked to conditions such as Duchenne muscular dystrophy and osteoporosis. Mesentech's proprietary technology overcomes the challenges of delivering medications to the difficult-to-treat bone environment, which often requires high drug doses and can lead to significant side effects. Through pre-clinical in-vivo models, the effectiveness of this bone-targeting system has been confirmed, positioning Mesentech to address various low-bone-density disorders and enhance bone healing outcomes. The company was incorporated in 2013 and continues to innovate in the field of bone therapeutics.
Claris Healthcare
Angel Round in 2019
Claris Healthcare Inc., founded in 2012 and based in Vancouver, Canada, offers a comprehensive communication platform that enables healthcare providers to effectively manage acute, chronic, and social care for patients at home. The platform includes solutions such as Claris Continuum for remote patient monitoring, Claris Companion for social isolation management, and Claris Reflex for rehabilitation post-acute interventions. These services are designed to require no on-site installation or training, allowing for immediate deployment and user accessibility. Claris Continuum assists providers in monitoring chronic conditions, while Claris Companion facilitates communication and oversight of aging loved ones, even for users with limited technical skills. Claris Reflex supports patients during their rehabilitation by providing timely advice and customized care programs. The platform's flexibility allows for various deployment options, including fully integrated kits and the use of patients’ own devices. This adaptability enhances patient engagement and satisfaction, promotes effective care management, and helps prevent hospital readmissions, ultimately supporting better health outcomes.
Claris Healthcare
Seed Round in 2018
Claris Healthcare Inc., founded in 2012 and based in Vancouver, Canada, offers a comprehensive communication platform that enables healthcare providers to effectively manage acute, chronic, and social care for patients at home. The platform includes solutions such as Claris Continuum for remote patient monitoring, Claris Companion for social isolation management, and Claris Reflex for rehabilitation post-acute interventions. These services are designed to require no on-site installation or training, allowing for immediate deployment and user accessibility. Claris Continuum assists providers in monitoring chronic conditions, while Claris Companion facilitates communication and oversight of aging loved ones, even for users with limited technical skills. Claris Reflex supports patients during their rehabilitation by providing timely advice and customized care programs. The platform's flexibility allows for various deployment options, including fully integrated kits and the use of patients’ own devices. This adaptability enhances patient engagement and satisfaction, promotes effective care management, and helps prevent hospital readmissions, ultimately supporting better health outcomes.
Starling Minds
Seed Round in 2018
Starling Minds Inc. is a Vancouver-based company founded in 2013 that specializes in digital mental health therapy. It offers an online Cognitive Behavioral Therapy program designed to address stress, burnout, anxiety, and depression in workplace settings. The company provides comprehensive solutions for various sectors, including business, disability management, education, healthcare, insurance, and workers' compensation. By utilizing an artificial intelligence-powered platform, Starling Minds licenses its technology to insurance payers, healthcare providers, and employers in a business-to-business model. This approach aims to alleviate the chronic shortage of affordable mental health professionals by offering effective support for employees, facilitating their return to work, and promoting overall workplace productivity and mental well-being.
CuePath Innovation
Seed Round in 2017
CuePath Innovation Inc. is a health technology company based in Vancouver, Canada, founded in 2015. The company specializes in developing a mobile application and smart disposable medication packaging aimed at helping caregivers monitor the medication intake of elderly patients and other vulnerable individuals. By facilitating remote tracking, CuePath's platform connects seniors with their caregivers and healthcare professionals, allowing families to ensure that their loved ones adhere to their medication regimens. This innovative approach not only promotes medication compliance but also supports the independence and health of seniors, thereby alleviating the stress associated with caregiving.
Aspect Biosystems
Seed Round in 2017
Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, focused on 3D bioprinting and tissue engineering. Founded in 2013, it develops bioprinted tissue therapeutics aimed at transforming disease treatment. The company utilizes proprietary microfluidic 3D bioprinting technology to create physiologically relevant living tissues, allowing for precise control over biomaterial composition and structure during fabrication. Aspect Biosystems offers contract testing services using its 3DAirwayALI human tissue model, catering to pharmaceutical firms and academic institutions engaged in research related to respiratory diseases. Through partnerships with leading researchers and industry innovators, the company aims to address significant challenges in regenerative medicine and advance the understanding of human tissue creation for medical research and therapeutic discovery.
Microdermics
Seed Round in 2017
Microdermics Inc. is a medical device company based in Vancouver, Canada, that specializes in a hollow microneedle delivery platform for the biopharmaceutical market. Founded in 2014, the company emerged from research conducted at the University of British Columbia. Microdermics designs, manufactures, and tests hollow metal microneedles aimed at enhancing the delivery of various therapeutics and traditional intramuscular vaccinations. Its innovative delivery system offers a low-cost, scalable solution that mitigates the risks associated with traditional hypodermic needles, such as accidental needle sticks and needle phobia. By providing biopharmaceutical companies with a unique means of differentiating their products, Microdermics contributes to the advancement of treatments, including those for biosimilars, while potentially reducing therapeutic doses through precision injection into the intradermal space.
Aspect Biosystems
Seed Round in 2016
Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, focused on 3D bioprinting and tissue engineering. Founded in 2013, it develops bioprinted tissue therapeutics aimed at transforming disease treatment. The company utilizes proprietary microfluidic 3D bioprinting technology to create physiologically relevant living tissues, allowing for precise control over biomaterial composition and structure during fabrication. Aspect Biosystems offers contract testing services using its 3DAirwayALI human tissue model, catering to pharmaceutical firms and academic institutions engaged in research related to respiratory diseases. Through partnerships with leading researchers and industry innovators, the company aims to address significant challenges in regenerative medicine and advance the understanding of human tissue creation for medical research and therapeutic discovery.
ViewsIQ
Seed Round in 2015
ViewsIQ is a medical imaging company headquartered in Vancouver, BC, Canada, that specializes in digitizing lab samples such as blood, urine, and tissue. Founded in 2010, the company has developed the Panoptiq product platform, which integrates into existing laboratory microscopy workflows. This platform allows clinicians to manage digital image quality effectively, enhancing the delivery of diagnostic information and improving patient outcomes. Panoptiq enables users to live stream, digitally scan, store, and share slides effortlessly while facilitating remote evaluations of intraoperative frozen sections. The software automatically sharpens out-of-focus areas within panoramic images, ensuring high-quality results. By providing real-time digital access to slides, ViewsIQ supports pathologists in maintaining efficient workflows and delivering high-quality care to patients globally.
Optigo Networks
Seed Round in 2014
Optigo Networks Inc. is a Canadian company based in Vancouver that specializes in optical networking solutions tailored for intelligent buildings. Founded in 2012, Optigo offers a range of products, including plug-and-play optical Ethernet switches, optical splitters, and optical electrical converters. The company's focus is on ensuring healthy operational technology (OT) networks that support various applications such as IP video surveillance, security access control, smart metering, and wireless mesh networking. By providing advanced monitoring and management solutions, Optigo helps simplify the complexities of smart building networks, allowing for seamless data movement between operational and information technology systems. Their offerings include Optigo Visual Networks for continuous monitoring and troubleshooting, and Optigo Connect for centralized network management. Serving clients through partnerships and sales representatives in Canada and the United States, Optigo Networks is committed to enhancing the functionality and sustainability of commercial buildings across diverse environments, from stadiums to data centers.
Semios
Seed Round in 2014
Semios specializes in providing crop management solutions for the agricultural industry. It offers a proprietary system of in-crop wireless networks coupled with remote sensors, pest monitoring, and variable rate biological pest control. This information is provided to the grower in an interface that allows the grower to reduce agricultural inputs and increase the quality of the crop produced. The company was founded in 2010 and is headquartered in Vancouver, British Columbia.
ImStar Therapeutics
Seed Round in 2014
ImStar Therapeutics Inc. is a biotechnology company based in Vancouver, Canada, established in 2012. The company specializes in developing treatments for amyotrophic lateral sclerosis (ALS), with a focus on addressing neurodegeneration. Its product pipeline includes IMS-088, a small-molecule compound targeting the immune system activation pathways involved in neurodegeneration, as well as TDP-43 Associated NF-kB Activation Inhibitors. ImStar Therapeutics aims to provide innovative therapies that can improve outcomes for patients suffering from ALS and potentially other neurodegenerative diseases.
Semios
Seed Round in 2013
Semios specializes in providing crop management solutions for the agricultural industry. It offers a proprietary system of in-crop wireless networks coupled with remote sensors, pest monitoring, and variable rate biological pest control. This information is provided to the grower in an interface that allows the grower to reduce agricultural inputs and increase the quality of the crop produced. The company was founded in 2010 and is headquartered in Vancouver, British Columbia.
BlueBat Games
Seed Round in 2013
BlueBat Games Inc. is an independent studio based in Vancouver, Canada, founded in 2011 by former EA software engineers. The company specializes in helping game developers and casino brands enhance player engagement through its innovative BlueBox Engine, which facilitates social gamification on browser-based and mobile platforms. BlueBox offers a suite of services, including user information retrieval, privacy management, and tools for building player identity and relationships. It also manages in-game currency and virtual goods, handles authentication processes, and provides analytics to empower game designers. In addition to its platform services, BlueBat develops gaming content, exemplified by its slot game, Lucky Bank's Penny Slots. As of 2015, BlueBat Games operates as a subsidiary of Greentube Internet Entertainment Solutions GmbH.
ImStar Therapeutics
Seed Round in 2012
ImStar Therapeutics Inc. is a biotechnology company based in Vancouver, Canada, established in 2012. The company specializes in developing treatments for amyotrophic lateral sclerosis (ALS), with a focus on addressing neurodegeneration. Its product pipeline includes IMS-088, a small-molecule compound targeting the immune system activation pathways involved in neurodegeneration, as well as TDP-43 Associated NF-kB Activation Inhibitors. ImStar Therapeutics aims to provide innovative therapies that can improve outcomes for patients suffering from ALS and potentially other neurodegenerative diseases.
Semios
Seed Round in 2011
Semios specializes in providing crop management solutions for the agricultural industry. It offers a proprietary system of in-crop wireless networks coupled with remote sensors, pest monitoring, and variable rate biological pest control. This information is provided to the grower in an interface that allows the grower to reduce agricultural inputs and increase the quality of the crop produced. The company was founded in 2010 and is headquartered in Vancouver, British Columbia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.